These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16173501)

  • 1. Helicobacter pylori vaccine development: facing the challenge.
    Aebischer T; Schmitt A; Walduck AK; Meyer TF
    Int J Med Microbiol; 2005 Sep; 295(5):343-53. PubMed ID: 16173501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current status of Helicobacter pylori vaccines: a review.
    Kabir S
    Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards the development of vaccines against Helicobacter pylori: status and issues.
    Del Giudice G
    Curr Opin Investig Drugs; 2001 Jan; 2(1):40-4. PubMed ID: 11527009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
    Harbour SN; Every AL; Edwards S; Sutton P
    Helicobacter; 2008 Dec; 13(6):494-9. PubMed ID: 19166414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in vaccination against Helicobacter pylori.
    Velin D; Michetti P
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):157-66. PubMed ID: 20350263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.
    Hoffelner H; Rieder G; Haas R
    Int J Med Microbiol; 2008 Jan; 298(1-2):151-9. PubMed ID: 17714988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
    Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
    Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccines against Helicobacter pylori.
    Del Giudice G; Malfertheiner P; Rappuoli R
    Expert Rev Vaccines; 2009 Aug; 8(8):1037-49. PubMed ID: 19627186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against Helicobacter pylori.
    Lee A
    J Gastroenterol; 1996 Nov; 31 Suppl 9():69-74. PubMed ID: 8959525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization against Helicobacter pylori--a future concept.
    Michetti P
    J Gastroenterol; 1998; 33 Suppl 10():66-8. PubMed ID: 9840022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant.
    Chionh YT; Arulmuruganar A; Venditti E; Ng GZ; Han JX; Entwisle C; Ang CS; Colaco CA; McNulty S; Sutton P
    Vaccine; 2014 Apr; 32(20):2350-8. PubMed ID: 24625340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Helicobacter pylori infection.
    Lee A
    Scand J Gastroenterol Suppl; 1996; 215():11-5. PubMed ID: 8722377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against H. pylori: an achievable goal].
    Ferrero RL
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):488-93. PubMed ID: 12700508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental model of Helicobacter pylori infection.
    Del Giudice G; Ghiara P; Rappuoli R
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S261-3. PubMed ID: 10077750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
    Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
    Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
    Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
    Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection.
    Aebischer T; Walduck A; Schroeder J; Wehrens A; Chijioke O; Schreiber S; Meyer TF
    Int J Med Microbiol; 2008 Jan; 298(1-2):161-8. PubMed ID: 17702653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine.
    Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM
    Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.